Advanced Cell Diagnostics Growth, Revenue, Number of Employees and Funding

Overview

Location:
Newark, CA USA
Total Funding:N/A
Industry:Biotech
Founded:2006
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Advanced Cell Diagnostics's estimated revenue is currently $25.7M per year.
  • Advanced Cell Diagnostics received $22.0M in venture funding in June 2015.
  • Advanced Cell Diagnostics's estimated revenue per employee is $144551

Employee Data

  • Advanced Cell Diagnostics has 178 Employees.
  • Advanced Cell Diagnostics grew their employee count by 8% last year.
  • Advanced Cell Diagnostics currently has N/A job openings.

Executive Contacts

NameTitle
Xiao-Jun MaChief Scientific Officer
Christopher BunkerVice President, Business Development
Deborah WrightVP RA/QA
Jessie WangChief Financial Officer
Ruby HsuDirector, Market Development
Tony LamVP Regulatory Affairs and Quality Assurance
Dan ZhangSenior Director Of Operations
Nathalie KochAssociate Director, Marketing at Advanced Cell Diagnostics
Tom O'LenicChief Commercial Officer
Henry LamparskiSenior Director (IVD) Product Development

What Is Advanced Cell Diagnostics?

ACD - a Bio-Techne brand, (www.acdbio.com) shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and tissue-based research and diagnostic tests for personalized medicine. Based in Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry. ACD's products and pharma assay services are based on its proprietary RNAscope® technology ( 1200+ publications in 6 years), the first multiplex fluorescent and chromogenic in situ hybridization platform, capable of detecting and quantifying single molecules of RNA in situ. ACD has two product lines, namely RNAscope and BaseScope(tm) in addition to a Pharma Assay Services business. The catalog includes >10,000 target probes and assay kits for single, duplex and multiplex RNA analysis. www.acdbio.com

keywords:N/A

178

Number of Employees

$25.7M

Revenue (est)

N/A

Current Jobs

8%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.2M4310%N/A
Mission Bio
$10.7M7445%N/A
Rigel Pharmaceu...
$42M2904%N/A
ProTrials Resea...
$26.4M1823%N/A
Trace Genomics
$5.9M4137%N/A
Advanced Cell D...
$25.7M1788%N/A
CellMax Life
$5.7M4011%N/A
Vaxart
$4.2M33-15%N/A
Full Spectrum A...
$6M425%N/A
Calysta
$7.1M49-2%N/A

Advanced Cell Diagnostics News

09/03/2019 - ?Global Cancer Stem Cells (CSCs) Market Outlook 2019 – 2025 : Janssen, Qiagen, Advanced Cell Diagnostics – Market Segment

Crucial players are analyzed Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, ...

09/08/2019 - Global RNA In Situ Hybridization Market 2019 – 2025 Abbott ...

... Analysis Of the global RNA In Situ Hybridization Market includes Abbott, Biogenex, Biosb, Roche, Sigma-Aldrich, Advanced Cell Diagnostics, ...

09/03/2019 - Circulating Tumor Cell Diagnostics Market Size Segmented by ...

A comprehensive research study on Circulating Tumor Cell Diagnostics market added by Market Study Report provides insights into the market ...

Advanced Cell Diagnostics Funding

DateAmountRoundLead InvestorsReference
2009-09-03$5.4MUndisclosedMorningside VenturesArticle
2012-11-02$12.0MUndisclosedNew Leaf Venture Partners, Morningside VenturesArticle
2015-06-19$22.0MCSummit PartnersArticle

Advanced Cell Diagnostics Executive Hires

DateNameTitleReference
2013-01-28Evangeline GonzalezChief Commercial OfficerArticle
2014-12-03Tom OlenicChief Commercial OfficerArticle
2015-12-17Robert J. MonroeChief Medical OfficerArticle